Other,negativelyCorrelatedWithLvef
Signature,intervalBetweenDiagnosis
Other,cutaneousManifestationsOfBreastCancer
Other,lungMetastasesFromBreastCancerPresented
Other,50PercecntRelapsedTissues
Other,twoUncommonCasesOfDelayedBreastCancerRelapses
Other,womenInWorld
Other,utilized
Other,mir-193b-3pBindingTo3UntranslatedRegionOfMorc4
Care,healthcareCost
Other,impairedBaselineCardiacFunctionExperience
Other,affected
Hazard,resultOfPreviousOrbitalBiopsy
Other,managementOfTumour-relatedSymptoms
Other,receiverOperatingCharacteristicCurves
Hazard,increasedRiskOfMortality/relapse
Care,standardOfCareForBreastCancer
Other,shallow-CNN
Other,oneRegionAnother
Other,breast
Biopsy,rightMastectomyWithSentinelLymphNodeBiopsy
Other,reverseTranscriptionQuantitativePolymeraseChainReaction
Cell,canStarted
Other,extensiveMolecular
Cell,weakToStrongReactivityToOtherCellLines
Other,16PrimaryBreastCancers
Targets,novelTherapeuticTargetsFor
Other,difference
Other,usuallyAssociated
Other,mass
Other,accessToReceptorAnalysesInCytosolAtDiagnosis
Other,lymphaticInvasion
Other,pathologicallyTumor-freeNodes
Image,mostCommonAdultCancersInKenya
Other,nslnMetastasis
Other,commonMalignantDisease
Other,treatmentTherapy
Other,significanceLevel
Other,uncommon
Other,CTIBL
Variants,244GermlinePathogenicVariants
Other,keysToSuccessfulChestWallResectionForLocallyRecurrentBreastCancerAfterMastectomy
Signature,response
Other,sideEffectsOfBreastCancerTherapiesIncludingHotFlushes
Other,visits
Other,sufferingFromWoman'sDisease
Other,primaryPurposeOfPeriodicMammogramsInScreeningProgramsIs
Other,cutoffValues
Other,inMultivariateModelsRelatedToPerformanceStatus
Other,asInCaseShouldAlwaysKeptInMindSpeciallyInHighVolumeCenters
Other,11Days
Other,rolePlayedByPdgfFamilyMembersInNormalDevelopmentOfBreastTissueDespiteItsPotentPro-lymphangiogenicEffects
Other,throughOptimizationTestsChosenAsOptimalConditions
Other,effectiveDiagnosisOfBreastCancer
Mechanism,associationStudy
Other,results
Other,WHI
Other,properAccessToDiagnosis
Toxicity,number
Other,novelInsightsIntoPotentialMechanismsAssociatedWithBreastCancerPathogenesis
Variants,244GermlineVariants
Other,controversial
Other,duringAgeAssociatedWithIncreaseOf8MoreFemaleBreastCancerCasesPer100000DuringAge50-54
Other,challenge
Other,activatedComplex
Other,reducedBaselineCardiacFunction
Other,growth
Other,C1
Other,heterogeneousCancerInFemalePatientsWorldwide
Other,finding
Susceptibility,thusInRecentYearsDemand
Other,irregularHyperintenseLesionInT2InLeftParietalRegion
Other,Ontario
Other,apoptosis
Other,moreSatisfiedWithTheirCosmeticResultsThanThose
Other,mayIndicativeOfBenignLesion
Other,rates
Mechanism,termsOfMechanism
Other,tumorGrowthInExperimentalModels
Survival,releaseProfile
Other,those
Other,injury
Other,real-time
Resistance,physicalActivityInPatientsWithMetastaticBreastCancer
Other,independent
Other,FFDM
Mechanism,significantAssociationBetweenLevelsOfNek6
Other,data
Other,currentlyInsufficient
Other,personalGoals
Hazard,outcomeInLymphedemaPatients
Other,pathogenesisOfBreastCancer
Other,threeDifferentUsMachines
Other,respectivelyFound
Other,moreInformationAboutFurtherStratificationOfBreastCancerSubtypes
Other,advantages
Cell,canHeavilyInfluenced
Neoadjuvant,administrationOfNeoadjuvant
Other,inCaseReportTypicalOfAdvance
Exposure,nomogram
Other,trastuzumab
Advantage,interest
Other,delaysinTreatment
Cell,canCategorized
Hazard,risk
Other,bronchoalveolarCarcinomaUnrelatedToKnownMetastaticBreastCancer
Other,T2
Other,expressionOfCxcChemokineReceptor-4
Other,inCaseSecondaryToProximalBronchialObstruction
Other,ultrasound
Other,defectStudies
Other,symptomaticWomen
Other,pre-operativeAssessment
Other,ICER
Risk,commonCauseOfMorbidity
Other,improved
Other,inTotalDiagnosedUnderAgeOf50
Other,researchers
Other,adulthood
Other,detected
Other,estimates
Other,associationsOfFactorsWithLocoregionalAtDiagnosis
Other,clinicopathologicalCriteria
Other,qualityOfLifeOfPatients'Spouses
Other,calculated
Other,40Percecnt
Other,breastCancerPatientsSerum
Cell,cellCycleArrestFollowedByMassiveCellDeath
Other,potentialOfAionAsEffectiveMultimodalContrastAgentForBreastCancerDiagnosis
Other,diagnosisOfEstrogenReceptor
Other,alteredInHumanBreastCarcinoma
Care,theirCare
Other,effectivenessOfDifferentNpatsOnQolInPatientsWithBreastCancer
Other,PFS
Susceptibility,proactiveManagementOfPsychologicalHealth
Other,betterResults
Signature,haveDescribedInResponseToNeoadjuvantChemotherapyParticularlyInAssociationWithHerceptinTreatment
Other,higher
Other,improvedDiagnosis
Other,haveStudiedInTermsOfCrosstalkBetweenEstrogenReceptorAlpha
Other,incidenceAmongMalignancies
Care,fearOfPartnerLoss
Other,oneRegion
Other,464Percecnt
Other,achieved
Other,importantInsightsIntoDiagnosisOfPatientsWithDisease
Other,successfulFunctionalizationOfNanocompositeOfSpecificSequenceOfAminatedComplementaryOligonucleotideOfMirna-21
Other,avoidance
Susceptibility,emergingPublicHealthProblemInLowCountries
Other,likelihood
Other,casesWithoutMetastasisOnDiagnosticImaging
Hazard,coxProportionalHazardModel
Other,presence
Other,patterns
Susceptibility,changesToIntimateIssuesIncludingSexualHealth
Other,drastic
Other,moreDirectional
Other,thereforeApplied
Cell,canIncluded
Other,increasedMalignantPotential
Other,tnmStage
Other,signatures
Other,adjacentNon-tumorousTissues
Survival,significantlyCorrelatedWithOverallSurvival
Other,spectrum
Other,23Studies
Other,thanCapecitabineGroup
Image,physicallyActive
Strategy,multimodalityTreatmentStrategy
Other,adherenceToRecommendationWith95PercecntConfidenceIntervals
Other,forefrontOfResearch
Heterogeneity,intratumoralHeterogeneityOfKindOfTumor
Mechanism,potentialMechanismForFoxc1-inducedMetastasis
Other,methylationStatusOfPcdh10InBreastCancerTissues
Other,C
Other,growthOfFbxo22-depletedEr-positiveBreastCancers
Other,importantTumor-promotingCells
Other,explored
Other,adherence
Other,patientsWithBreastCancerReceivingWithAnthracyclines
Other,thatOfOtherCountries
Other,withDevelopmentOfHigh-throughputSequencingHaveDiscoveredInTumorousTissues
Other,gynaecologicalMetastases
Autoantibodies,multiplexedAssayForDetectionOfAutoantibodiesInCanineTumours
Other,0.003
Care,extensiveAttentionOfResearchers
Technique,additionalLocalControl
Other,developmentOfBrainCancers
Other,negativeMargins
Other,higherRisksOfTreatmentDelays
Other,levelsOfEralphaProtein
Other,indicatorOfNacEffectiveness
Advantage,goodCorrelationBetweenErAnalysedWithCytAtDiagnosisAnalysedWithIhcInArchivedFfpeTissueFromSameTumour
Other,functions
Other,genes
Other,mostEffectiveTechniqueused
Other,kaplan-meierRegressionMethods
Other,widelyExpressed
Cell,canIncludedInDifferentialDiagnosisOfMasses
Other,approaches
Other,copyright
Exposure,itsPerformance
Other,diagnosisOfPatientsWithBreastCancer
Vitro,bindingToBreastCancerCellsInVitro
Advantage,widespreadInterest
Other,described
Hazard,breastCancerRisk
Other,shaped
Other,.021
Glycosylation,glycosylation
Hereditary,geneticMutation
Mechanism,patternsOfAssociationResults
Other,serumSamplesFromCancerPatients
Other,876PercecntRespectively
Other,area
Other,significantChallenge
Survival,obtainedFrom66FemalePatientsWithMAtDifferentTimeIntervalsForEvaluationOfCtcsByFlowCytometry
Survival,survivalDifferences
Other,positive
Other,factor
Resistance,endocrineTherapyResistance
Other,hasFocused
Resistance,resistanceToMultipleTypesOfTreatmentInBreastCancerModels
Other,isSentinelLymphNodesMetastasesTo1-2Nodes
Other,compared
Other,haveBackboneOfSuchEnormousStridesOfAu
Other,site-specificBindingLeadingToImprovedCancerTreatmentWithMinimalRisksToNormalCells
Other,13-hDailyOvernightFast
Symptom,goodQualityEvidence
Other,mostEuropeanCountries
Advantage,advantage
Other,thusAimed
Other,cssBenefit
Other,developmentOfPolicies
Other,largelyConsistent
Other,severalObjectives
Other,diagnosisOfSulinicalPrimaryCarcinomas
Other,bestChancesOfCure
Other,surgery
Other,pregnancyFrom1959To1966
Other,mustAddressed
Other,pairedUntreatedPrimaryTumor
Other,factorsRelatedToPresenceOfMetastaticDiseaseAtDiagnosis
Oxidation,greaterthanorequalto10PercecntReductionInLvef
Other,generalBreastCancerPopulation
Other,tumorSuppressorGene
Strategy,potentialTreatmentStrategyForEndocrine-resistantBreastCancers
Other,rationaleForTamsAsTherapeuticTargetInBreastCancer
Other,differentiallyExpressedInBreastCancerCells
Other,onlyWomen
Other,n-typeVoltage-gatedV-gCalciumChannelBindingAntibodies
Mechanism,significantAssociationBetweenRs5743810AllelicFrequency
Other,haveClarified
Other,influences
Other,mayUsed
Other,alsoAssessed
Other,differentmethodsOfSelf-treatment
Other,510YearsAfterSurgery
Other,stable
Other,aberrantlyExpressed
Other,pleurodesisForMalignantPleuralEffusion
Other,retrospectiveObservationalStudyOf264Her2-positiveAdvancedBreastCancer
Other,outcomesOfEstrogenReceptorPositive
Other,preliminaryGroupOfCtibl
Other,seValues
Other,consequentlyHaveDeveloped
Other,conventionalBafifty-fivePatientsUndergoingViaMabaForPtmc
Other,assessedinclusionCriteriaForEnrolment
Other,differentDetectionRatesInBreastCancerPatients
Other,dissection
Other,electricalDouble-layerCapacitors
Other,willUsedAsReferences
Other,peripheralBlood
Other,termsOfClassification
Other,detection
Other,correlated
Other,retrospectiveStudyOfWomenTreatedWithTrastuzumabForHumanEpidermalGrowthFactorReceptor2BreastCancerAtMayoClinicBetweenJanuary12000
Other,standardizedDataCollection
Other,singleMetastaticSite
Other,an
Other,breastCancerYoungerThan45Years
Hazard,resultCompatibleWithMetastasisToOrbit
Other,able
Other,likelihoodOfDetectionOfMicrometastases
Other,humanLife
Other,womenOfReproductiveAge
Symptom,symptomBurden
Other,evenMorePersonalizedFollow-upSchedules
Other,ca15-3ByCmia
Other,developmentOfGraphicallyTailoredScreeningTool
Other,additionallyRevealed
Other,significantlyYoungerAge
Other,992Percecnt
Susceptibility,researchLight
Other,prognosticFactorIndependentOfOtherClinicalVariables
Other,particularEmphasisQuantifying
Other,times
Other,effectsOfPcosOnRisksOfGynecologicCancer
Other,howeverMoreDrastic
Other,images
Hazard,riskFactors
Other,currentResults
Other,sparseCombinationOfRiemannianDictionaryAtoms
Other,mostFrequentCancerInWomenTreatedWithHormonalTherapy
Other,recognized
Radiotherapy,ourExperienceOfHigh-doseRadiotherapy
Other,proposed
Other,proposedForBreastTumorGrading
Township,thenLinkedToTownshipFemaleBreastCancerIncidenceRateIn2000s
Other,significantlyProlongedMedianPfs
Other,howeverNon-ideal
Resistance,chemotherapyResistance
Other,mistaken
Other,indispensable
Other,appliedTo70PatientsWithUnilateralRl
Other,otherSubtypesOfBreastCancer
Other,analysisInvestigate
Other,potential
Other,0.007
Other,breastCancerClassification
Other,worldwideHighestAge-standardizedBreastCancerIncidence
Other,NMA
Susceptibility,changesInHealthBehavioursAfterBreastCancerDiagnosis
Other,theirBeliefsRegardingCancerCausation
Other,mainlyPostmenopausalWomen
Other,single-cellWhole-exomeSequencing
Cell,canClassified
Other,crucialRole
Susceptibility,moodOfLife
Other,accuracy
Other,consensus-based
Other,alternativeToFrozenSections
Other,CNVs
Other,reported
Other,understudiedPattern
Other,progressionOfTumorInvasionInBreastCarcinoma
Other,real-worldSetting
Resistance,anti-tumorActivity
Hereditary,identificationOfDistinctiveGeneticModificationsInDifferentBreastCancerMolecularSubtypes
Other,descriptive
Other,whenonlyAnalyzed
Other,diagnosis
Other,her2/hrTripleNegativeTnmStages
Other,underutilized
Other,additionallyCorrelated
Other,diagnosisAccuracy
Other,promising
Other,elusive
Other,diagnosisOfCancer
Other,recentlyDiagnosedBreastCancer
Other,unilateralBreastCancer-relatedLymphedema
Cell,panelOfMonoclonalAntibodiesAgainstNewlyEstablishedCellLine
Other,disposition
Other,ligand-bindingDomainAllInBreastCancerSamplesFromPatientsPreviouslyTreatedWithEndocrineTherapy
Other,subsequentLung/bronchusMalignancies
Other,performed
Other,clinicalPractice
Hazard,associatedWithBreastCancerRisk
Cytology,breastCancerGeneticsInKenya
Other,imagingInvestigations
Other,38Months
Other,2009-13
Other,penalizedLogisticRegression
Cell,canEasilyExtended
Other,pathologicEvaluation
Other,spindleCells
Other,assessedPreoperatively
Exposure,backgroundParenchymalEnhancement
Other,firstTimeIn1984
Survival,releaseFromSerumStarvationInMcf-7Cells
Other,potentialImportanceAsModelsForHumanBreastCancer
Other,3-timeAssessments
Other,rare
Other,tumorImaging
Survival,flowCytometry
Other,undiagnosed
Vulnerability,associationBetweenNsaidsExposureInFemalePatientsWithAd
Other,likely
Other,occurrenceOfBreastCarcinoma
Other,fewerInstancesOfSpreadToLungs
Other,CXCR4
Other,normalSamples
Strategy,potentialTreatmentStrategy
Other,twoLargeBreastCancerDatabases
Other,theirParticularity
Hazard,increasedRiskOfEndometrialCancer
Cell,cancer-relatedEventsIncludingTumorCellMigration
Other,Porto
Other,public
Other,inBreastTumorsKnownAsBreastCscs
Other,inConclusionPathogenicFeatureInPrimarySamples
Other,clinico-epidemiologicalFeaturesOfBreastCancer
Other,magneticResonanceImaging
Hazard,eventHybridizationOfMirna-21Biomarker
Susceptibility,stillSeriousHealthProblemIn21stCenturySubjectToManyResearch
Other,twoGroups
Susceptibility,danger
Other,tumourSpread
Mechanism,humanBody
Other,haveReportedForFirstTimeInCaninesInStudy
Neuromas,only35CasesOfTraumaticBreastNeuromas
Other,heterogeneous
Other,breastCancerIncidence
Paraneoplastic,likelyParaneoplastic
Other,minimal
Other,importantProblem
Other,place
Other,expected
Other,unmetPsychosocialNeeds
Other,sameRangeAsCasesWithoutWavelength-dependentMeasurementErrors
Other,mostCountries
Other,disseminatedDisease
Other,hasPut
Resistance,dealingWithEndocrineResistanceInPatientsWithBreastCancer
Other,incidenceFactorsOfSubsequentLung/bronchusPrimaries
Other,immediateUnmetNeedInClinicalPractice
Other,YS
Township,township
Other,thenAdded
Other,detectionRate
Other,synonymous
Other,ribonucleotideReductaseM2
Other,year
Other,furthermoreSignificantlyMoreLikely
Other,6Months
Other,predominant
Other,comparedBetween2GroupstheApatinib
Toxicity,variousLimitationsIncludingToxicity
Other,505Percecnt
Other,designed
Other,Kenya
Other,importanceOfNondestructiveTestingInDefectStudies
Signature,key
Other,two-thirdsOfBreastCancerCases
Other,attempted
Other,highestIncidenceAmongMalignanciesDiagnosedInWomen
Other,iU22
Other,level
Township,shanxiProvinceOfChina
Risk,cause
Other,manufactured
Advantage,betterOutcomeWithGoodNegativePredictiveValue
Other,effectsOfTreatment
Other,tumorBurden
Other,significantlyHigher
Other,divided
Other,pathologistAnnotation
Other,needForAnalysisOfMetastaticTissuesAtRecurrence
Other,her2-positiveA
Other,768PercecntSamplesWithOverexpressionIn76Cases
Other,their
Other,performedInFemaleParticipantsWithBreastCancerFromJune2015ToDecember2017
Other,tumorSuppressorFunctionOfP53InPathogenesisOfBreastCancer
Other,shouldProcessed
Other,practitionerDecisionmaking
Other,18.791
Other,haveDeveloped
Other,forThoseWithNormalLvef93Percecnt
Other,haveObserved
Other,regulated
Strategy,inWorkSynthesizedAsSystemForDeliveryOfDoxorubicinInTreatmentOfBreastCancer
Other,meanwhileBetterThanInCapecitabineGroup
Other,knownHeterogeneousDisease
Other,nf-krab-inducedIncreasedExpressionOfCcnd1
Other,pCR
Other,clinicalSetting
Cell,g1/s-phaseCellCycleArrest
City,howeverGreaterforPatientsTreatedInAlmatyCity
Other,percecntRelapsedTissues
Other,protectiveRoleOfRs5743810
Other,developmentOfNewDrugs
Other,sometimesMistaken
Other,firstDataOnPre-diagnosisConcentrationsOfSrankl
Other,given
Other,administered
Other,chances
Other,significance
Other,chronicDebilitatingLifelongComplication
Other,treatmentMoreAccessibleToBreastCancerPatients
Other,appropriateDiagnosisOfBreastCancer
Other,necessary
Other,differenceBetweenClearcellPlatformsForIsolatingCtcs
Other,30TBreastMagneticResonanceImagingExaminations
Other,normalCardiacFunction
Other,generalPopulation
Susceptibility,collectedFromElectronicHealthRecord
Other,youngAge
Other,MP
Other,collisionTumorWithBreastCancerMetastasis
Other,MortalityRates
Other,molecularDiagnosisMethodMake
Other,treatedWithIntraperitonealInjectionFor30Days
Other,imaging
Other,mostInvasiveDisease
Other,postponementVisiting
Other,spouses
Other,formulationOfEffectiveManagementPlanForAt-riskWomen
Other,suggested
Other,high-resolutionImages
Care,scalableIntervention
Other,treatedWithCapecitabineMonotherapyAsThird-lineTherapy
Other,preoperativeCytologicalDiagnosisOfBreastCancerMetastasesInRegionalLymphNodesIn84Patients
Other,time
Other,fbxo22-dependentManner
Other,oftenHypomethylated
Other,imagingModalities
Other,relevant
Other,signalAmplificationStrategies
Other,relationship
Susceptibility,acuteDangerToMother
Hazard,increasedRiskOfTherapy-relatedMorbidity
Other,properties
Comorbidities,moreComorbiditiesThanSPatients
Phenotype,roleOfImage-basedTextureFeaturesAsNoninvasivePrognosticBiomarkers
Other,initialPresentationOfInvasiveBreastCancer
Other,immune-mediatedCancer-associatedDisorders
Other,examined
Other,905Percecnt
Other,SE
Other,influenceOfSleepQualityOnPmInPatientsTreatedWithHt
Other,Israel
Hazard,worseOutcome
Mechanism,associationBetweenPost-diagnosisLow-doseAspirinUse
Care,clinicalCare
Other,haveProducedInLaboratories
Other,desirable
Other,inConclusionStronglyAssociatedWithNonparticipationInS
Susceptibility,healthExpectancyOfItspopulation
Other,normalTissues
Other,axillaryLymphNodeOfBreastCancerPatients
Other,overexpressed
Other,significant
Other,support
Other,5CmLess
Other,workflowConsistingOfImmunoaffinityPurification
Other,demonstrate
Hazard,highlyDiverseGroupOfMalignantNeoplasiaWithPoorOutcome
Other,comparisonOfPredictedIncidenceOfBreastCancerWithActualIncidenceInPopulation-basedStudies
Other,sample
Technique,breastCancerControlEffortsForIdentification
Other,available
Other,higherRatesOfMisdiagnosisForBreastCancer
Other,autonomyOfPatients
Other,shouldCo-managedByCardiologist
Other,evidencedByIncreaseInContrastAfterInjection
Other,treatments
Other,expressionLevel
Toxicity,increaseWithNumberOfSprays
Other,canineTumours
Other,decreasedGrowth
Other,benignBreastLesions
Other,options
Biopsy,sentinelNodeBiopsy
Other,themselves
Other,dataOfN=
Other,femaleSibling
Other,mastectomies
Other,development
Cell,canImportant
Other,Japanese
Hazard,20PercecntIncreasedRiskOfBreastCancerAmongCurrentHormonalContraceptionUsers
Comorbidities,comorbiditiesThanSPatients
Other,oftenRelated
Other,established
Other,imperative
Other,FT
Other,vitalRole
Other,mutationalStatusBesidesFamilyHistory
Other,thoughtfulMultidisciplinaryPlanning
Symptom,effectOfDscam-as1
Susceptibility,improvementInClassificationOfMalignantLesions
Other,haveReportedMainlyAfterMastectomy
Other,SRC
Other,earlyCancerDiagnosis
Other,highlySensitiveNano-biosensor
Other,percent
Other,excision/lumpectomy
Other,team
Other,therapeuticEffectsInBreastCancer
Other,offered
Other,imagery
Other,alsoShaped
Strategy,policyActions
Resistance,greatPotentialOfClinicalApplication
Township,prognosisOfPatientsWithMaleBreastCancerInShanxiProvinceOfChinaFrom2007To2016
Other,1
Other,womenWithG
Other,tool
Targets,targets
Advantage,mayGoodChoiceForUnilateralPtmc
Other,bilateralSalpingo-oophorectomy
Other,0.46
Other,geneExpressionUpregulationInBreastCancer
Other,moreRecentlyHaveDeveloped
Other,mostFrequentlyOccurringCancer
Other,lymphNodeMetastasisInPatientsWithBreastCancer
Other,hospitalFromJanuary2016ToFebruary2017
Other,grade
Other,inCanadaOfferedInOrganizedPrograms
Other,731Percecnt
Other,fieldOfBreastCancerDetection
Other,immunohistochemicalDetectionOfErPerformedInRoutineClinicalPractice
Other,risk/benefitOfDifferentTreatmentModalities
Other,evaluated
Other,termsOfKyotoEncyclopediaOfGenes
Other,areaUnderReceiverOperatingCharacteristicCurve
Quantification,quantification
Other,added
Strategy,mightPromisingTherapeuticStrategyForHormone-therapyRefractoryEr
Other,her2-positiveInvasiveDuctalCarcinoma
Other,relationshipBetweenNlr
Other,theirExperiencesLivingWithSister
Susceptibility,variablesPredictiveOfNippleAreolaComplexInvolvementInPatients
Other,trastuzumabTherapy
Other,additionalIndicator
Other,couldPotentialBiomarker
Technique,inexpensiveTechnique
Other,increased
Other,capecitabineRegimenAsThird-lineTreatmentForAdvancedTriple-negativeBreastCancer
Other,haveDiscovered
Other,observations
Other,RRM2
Other,moreAdvancedStagingAtDiagnosisInWomen
Other,rituximab
Other,stratifyingForAge
Resistance,thusWouldCrucialForApplicationOfPreventiveStrategies
Other,historyOfBreastCancer
Other,linearRegression
Other,foxc1-knockdownBt549Cells
Other,third
Other,description
Other,ourExperience
Other,urgentlyAdvanceImplementation
Other,hasFound
Phenotype,structureChanges
Other,immunohistochemicalTests
Exposure,highestPerformance
Other,reducedBaselineLvef
Other,inAdditionFurtherConfirmedInEarlyStage
Other,non-nsaidUsers
Mechanism,alarm
Other,withandControllingForTreatmentDelays
Other,prospectivelyFollowedFor3YearsSinceDiagnosis
Biopsy,openBiopsyOfNodularityAttachedToPectoralMuscleFascia
Other,over-represented
Other,inFluorescenceImaging
Other,incidenceFactors
Other,relation
Other,downregulated
Other,shorterIntervalsBetweenD
Other,created
Other,Stem-likeCells
Toxicity,cytotoxicityOfFreeDoxMolecules
Exposure,assessmentOfImpactOfAdvancesInDiagnosisOfPatientsWithBreastCancer
Other,haMoietyForPdt
Other,personalizedFollow-upSchemes
Other,similarTendencyRelatedWithPrognosticFactors
Other,modeled
Other,enhancedPossibility
Other,years
Other,clinicalBreastCancerTrials
Other,sensitivity
Radiotherapy,needForNodalRadiotherapyInSpecificSituations
Other,generalRadiologistAboutSystemicDiseases
Other,elusiveToTargetedTherapies-theTriple-negativeBreastCancer
Radiotherapy,timingOfChemotherapyForBreastCancersWithDifferentMolecularBackgrounds
Other,targetRelationshipBetweenDscam-as1
Other,comparisonToCa15-3
Other,identifiablePcrResults
Other,time-varyingPost-diagnosisLow-doseAspirinUse
Other,shouldProceede
Other,betterPrognosis
Other,subtyped
Other,nowAlsoWidelyUsed
Other,shown
Other,therapeuticAdvantagesParticularlyInCaseOfPremenopausalBreastCancers
Image,activeNon-participants
Risk,mostProminentCause
Other,bayesianNetworkMeta-analysis
Susceptibility,haveAssociatedWithNippleAreolaComplexInvolvementInPatientsWithBreastCancer
Other,1973To2014
Other,fiveGroups
Other,themVeryDifficult
Other,locallyAdvancedBreastCancer
Other,factors
Other,howeverKnown
Other,13PercecntOfDeaths
Other,theirAbilityOfPrognosisPredictionInTheirOriginallyTargetedPopulationsOfBreastCancer
Other,oneRandomlyAssignedToAxillaryDissection
Advantage,goodDiagnosticAbility
Technique,ourFacility
Other,195Years
Other,stronglyPositive
Other,highlyEffective
Other,willDifferent
Other,M
Other,1Year
Other,mayNecessary
Other,thriceHigher
Other,essential
Other,forefront
Other,0.32
Other,shouldKept
Other,breastCancerScreening
Other,incompleteExcisionOfMalignantTissues
Other,tumorigenesisOfBreastCancer
Mechanism,associationOfToll-likeReceptor6WithBreastCancerInSaudiArabianWomen
Other,typicalWoman'sDisease
Other,up-regulated
Other,better
Other,consultations
Other,mostCommonCancerInWomen
Other,defined
Other,10Percecnt
Other,significantIncrease
Other,supportVectorMachine
Other,frequentLargeSingleGiantCellsWithNucleiLocatedPredominantlyWithinSupsularSinuses
Vitro,infraredFluorescentImagingInTripleNegativeInVitro
Other,21Months
Other,synthesized
Survival,presentedWorkForFeatureExtraction
Other,henceMainlyBased
Other,howeverElusive
Other,Cells
Other,90Percecnt
Other,testing
Other,6084Years
Other,131Percecnt
Other,tested
Other,lowerInEasternThanNorthern/centralEurope
Other,alcoholConsumption
Strategy,revisionsOfAjccBreastCancerStagingSystem
Other,invasion
Other,leftParietalRegion
Other,vap-1ImmunohistochemicalStaining
Cell,cellMigration
Other,independentPrognosticFactorForDfsOfEarlyStageBreastCancer
Other,serious
Other,mda-mb-231Cells
Other,forWomenWithBreastCancerMayMoreFeasible
Other,treatmentOfBreastCancer
Other,significantlyCorrelatedWithTumorSize
Other,aspirinUse
Township,accurateViewOfStateOfMetastasesToAxillaryLymphNodes
Other,weak
Survival,breastCancerPatientsWithParticularReferenceToOverallSurvivalAndrecurrenceFreeSurvivalAmongBreastCancerPatients
Other,17MillionPeopleWorldwide
Other,initiationOfPromptTherapy
Other,relativeThoseOfPostmenopausalPatients
Other,understood
Other,120Patients
Other,variousEnvironments
Susceptibility,whenIntegratedWithinCountry/region'sHealthPlan
Other,highVolumeAcademicCenters
Other,onlySubgroupWithProgesteroneReceptor
Other,moreoverPoor
Other,uniqueProperties
Other,oestrogenReceptorPositiveIn58PercecntOfCasesPositiveIn62Percecnt
Other,hasMadeInMolecularSubtypingOfBreastCancer
Other,lesion
Other,shouldElaborated
Other,goal-setting
Other,inStudyDevelopedByCell-selex
Other,breastCancerScreeningProgramme
Other,processes
Other,nirProbe
Other,them
Symptom,existingEvidenceOnPersonalGoal-settingAmongWomenWithBreastCancerDiagnosis
Cell,cellProliferation
Other,confirmed
Other,commonPlatformForStakeholdersIncludingPolicymakers
Other,m
Exposure,performanceEvaluation
Other,subsequentMalignanciesForLung/bronchusCancerWith13PercecntSurvivorsSufferedFromSubsequentMalignancies
Other,successOfSymmetricPositiveDefiniteMatrices
Other,quality
Other,stratification
Other,critical
Other,currentUsersOfLongerDuration
Other,objectives
Other,scrutinized
Strategy,treatmentStrategy
Mechanism,stableBodyWeight
Other,exon32OfMammalianTargetOfRapamycin
Vivo,selectiveAccumulationOfFluorescentOsteopontinInVitroAndInVivo
Image,netherlandsCancerRegistryOf37230PatientsWithEarlyBreastCancer
Other,firstPatientsWithPathologicallyTumor-freeNodes
Other,diverse
Other,hasUsed
Radiotherapy,theirRelatedMarkersAtDifferentPointsOfChemotherapyRegimensInMetastaticBreastCancer
Other,novelNear-infraredNirFluorescentProbe
Other,commonMedications
Other,uptake
Other,lessLikely
Other,obtained
Other,4.71
Susceptibility,commonEndocrineDisorder
Cell,canEffectivelyTreatedByEndocrineTherapy
Resistance,conflict
Phenotype,closedLoopStructure
Other,deep-CNN
Other,highestSeInTotalGroup
Other,complication
Other,probe
Other,addition
Quantification,successfulQuantificationOfCa15-3InSerumSamplesFromCancerPatients
Other,comparison
Other,about30Percecnt
Other,medianFollow-upOf9·
Other,betterOutcomes
Other,annualMammographyAssociatedWithEchography
Survival,progression-freeSurvival
Other,mostCommonNeoplasms
Other,95PercecntConfidenceIntervals
Other,electiveCholecystectomyForSymptomaticCholelithiasis
Other,typeOfCollisionTumor
Resistance,panelOf25GenesInvolvedInMechanismsOfTargetedTreatmentResistanceIn16PrimaryBreastCancersDevelopedDuringTreatment
Other,concentrationsOfVegf-aInComparisonToCa15-3InBreastCancer
Other,one-waySensitivityAnalyses
Other,clinicalSettingOfPreviouslyVagueDiagnosisInImaging
Other,despiteTheirRarityShouldConsidered
Other,infraredFluorescentDye
Other,after6Months'TherapySignificantlyHigherIn3rdTertiaryGroup
Other,consensus
Other,shouldCo-managed
Other,life-threatening
Radiotherapy,correctionMethod
Other,patients'MedicalRecords
Other,observed
Other,iraqiWomenWhencomparedToWesternWorld
Other,dramaticallyIncreasedAmount
Hazard,non-standardLessPromptTreatmentsIrrespectiveOfComorbiditiesWithIncreasedRiskOfMortality/relapse
Other,suspected
Susceptibility,pb-ctMode
Other,tests
Other,firstFiveFacebookOpenBreastCancerGroupsInYear2016
Other,bone-modulatingAgents
Other,facilitatingRole
Hazard,riskOfBreastCancerInAdulthood
Other,urgentlyNeeded
Mechanism,bodyMassIndex
Other,secondary
Other,furthermoreAssociated
Symptom,evidenceForbenefits
Other,tightDoctor-patientCollaboration
Other,genesInvolved
Other,fusionProteinsWithHaloTag
SNVs,SNVs
Other,totalHemoglobinConcentration
Other,approximately75PercecntOfBreastCancers
Other,hasAssociated
Correlation,uncouplingOfInverseCorrelationBetweenBmi
Other,differentHistologicalAspects
Other,staging
Other,differentBreastCancerMolecularSubtypes
Survival,littleSurvivalVariance
Other,type
Toxicity,increasingNumber
Other,importantComponent
Other,values
Susceptibility,automaticIntraoperativeIdentificationOfBreastCancerMargins
Other,centralDenmarkRegion
Other,employed
Other,highAmountOfDox
Other,89FfdmCases
Mechanism,body
Other,strongIndependentPrognosticFactor
Other,differentiationBetweenBreastCancerInVariousSubtypesOfBreastCancer
Other,sulass
Other,mostFrequentlyDiagnosedCancer
Other,hypomethylated
Other,inception-v3Cnn
Other,bareCapillaries
Other,southernPortuguese
Other,keys
Other,10.1
Other,cnvsOfDifferentCancers
Technique,rangingFromDiagnosisPhaseToControlOfDisease
Other,amplifications
Other,platform
Other,paper
Other,standardMethod
Other,considered
Other,prevention
Other,use
Image,energyImage
Other,correspondingCohort
Other,couldConsidered
Other,scalable
Other,therapy
Other,responsible
Other,inPaperUsed
Other,itInvolvesInManyCrucialMetabolicProcesses
Other,youngerBreastCancerSurvivors
Other,noted
Other,cancerDiagnosis
Care,maintenanceOfErCancerStemCells
Susceptibility,specificallyPlacedOnInflammatoryBreastCancerWithSkinInvolvementOnCutaneousMetastasesToBreastFromBreastCancer
Exposure,limitedPerformanceForWomenWithDenseBreasts
Other,patients'Self-monitoring
Symptom,effect
Other,contexts
Image,enhancementOfImage
Other,veryRareCaseOfTraumaticBreastNeuroma
Other,moreAggressiveBiologicalNatureThanPureDcis
Survival,synchrotronRadiation
Vulnerability,consensusOnAssociationBetweenExposureToDdt
Other,unusualCaseOfPtosis
Other,neonatal
Radiotherapy,isReplacedWithRadiotherapyInSituations
Other,limitations
Other,necessity
Other,betterDiagnosticAccuracyThanFfdm
Other,adjuvantAnastrozole
Other,following
Other,down-regulated
Other,moreDesirable
Other,noninvasive
Mechanism,associationBetweenPost-diagnosisUseOfLow-doseAspirin
Other,need
Other,role
Other,consistent
Other,oncogenesEsr1
Susceptibility,positiveChangesInTheirHealthBehaviours
Other,severalOtherGenes
Other,diseaseDefinedByTumor
Other,properImaging
Other,inPresentStudyPerformedFor9Features
Other,er-positive/humanEpidermalGrowthFactorReceptorType2-negativeBreastCancers
Other,advancesInBreastCancerDiagnosis
Other,773Percecnt
Other,promisingTherapeuticTargetForBreastCancer
Other,diagnosisOfAcuteCoronarySyndromes
Technique,control
Other,represented
Other,old
Other,0.00001
Other,tackled
Other,profile
Other,interimStageInProgressionFromDcisToInvasiveBreastCancer
Other,poorPrognosis
Other,doxUptakeByCs/bio-mof
Other,4Domains
Other,pureDcisInClinicopathologicCharacteristics
Short-term,promisingShort-termStrategiesPriorToTreatmentAdministration
Other,prohibitivelyExpensive
Other,inStudyDevelopedForHighlyEfficientIsolationOfCtcsFromBreastCancerPatients
Other,proteinExpressionOfNf-krab-p65
Other,screening
Other,initiationOfBreastMalignancy
Other,thusMeaningful
Other,discrete-timePartiallyObservableMarkovDecisionProcess
Other,cruciferousVegetables
Other,indicator
Other,recommended
Other,challengingProblem
Other,byDevelopmentOfHybridomaTechnologyHaveProducedInManyLaboratories
Other,antibodyDrugConjugates
Other,autopsyStudies
Hazard,increasedRisk
Other,product
Long-term,long-termEstimates
Other,youngerAge
Mechanism,variousOtherCancerInHumanBody
Other,familyHistoryOfDisease
Other,significantlyDecreased
Other,her2Overexpressing
Care,healthcareUtilization
Other,182Percecnt
Other,couldDetectedByMammographyBySelf-detection
Other,5-khzFrequencies
Other,operablePatients
Other,documentedAsImportantTumor-promotingAgentForSeveralHumanCarcinomasIncludingBreastCancer
Other,differentPatientRaces
Other,kaplan-meierCurves
Other,moreRecommended
Other,pre-diagnosticObesity
Other,westernBlot
Other,metastasisFromLobularBreastCarcinoma
Other,pool
Other,v-gCalciumChannelBindingAntibodies
Other,criticalRole
Other,importantForDiagnosis
Other,awareness
Care,mustIndividualizedWithEmphasisOnOptimalCareOfMother
Other,posteriorFossaOfBrain
Other,amongThemNewlyIdentifiedInStudy
Other,retrospective
Other,lung/bronchusMalignancies
Subtype,triple-negativeSubtypeMda-mb-231Cells
Other,haveReported
Other,invasiveDiseaseretrospectiveAnalysisOf219Cases
Other,outcomes
Other,only1ulOfSerumSample
Other,algorithm
Other,generallyReserved
Radiotherapy,chemotherapy
Other,atEndOfFollow-upClassifiedRegardingTheirAdherenceToRecommendationsForCancerPrevention
Other,tumorNeoangiogenesisSimilarToBreastMagneticResonanceImaging
Other,ageOfTreatmentMethods
Other,formulation
Other,17Years
Other,mostPrevalentType
Other,variousRadiologicalChangesLeadingToDiagnosticChallenges
Other,linked
Other,made
Other,largeCells
Other,haveReportedInOnly003-06PercecntOfBreastCancers
Other,her2Status
Survival,survivalVariance
Susceptibility,health
Hazard,riskOfDeath
Other,typicalHormone-dependentTumor
Other,major
Correlation,expectedInverseCorrelationOfSerumDdtsWithBmi
Other,statisticallyCorrelated
Other,isReplaced
Care,healthCareSector
Cell,breastTumorProgressionIncludingTumorCellGrowth
Other,nano-biosensor
Other,414Percecnt
Other,microfluidicsBiomarkerDetection
Other,evolve
Other,evolveTowardLessSurgery
Other,histologicGradeInBreastCancer
Other,therapy-relatedConditionsDuringBreastCancerSurvivorship
Other,trastuzumabTherapyForBreastCancer
Other,improvedQualityOfLife
Other,groups
Other,NLR
Other,cancer-relatedDeathsAmongWomen
Care,cancerCareNetwork
Other,classified
Other,differentPhotosensitizerForPhotodynamicTherapy
Other,theirOriginallyTargetedPopulationsOfBreastCancer
Other,feasible
Strategy,antibody-basedStrategy
Other,importanceOfProactivelyAddressingFertility
Other,diagnosisOfGallbladderMetastasis
Other,breastCancerTissues
Other,cancerTreatment
Other,increase
Hazard,strongAssociationBetweenRs5743810AgainstRiskInSaudiArabianWomen
Other,gtpaseInBreastCancerCells
Other,combination
Other,prognosticSignificanceOfNeutrophil-to-lymphocyteRatioInPatientsWithBreastCancer
Other,lossOf020Quality-adjustedLifeYears
Other,understudied
Other,negativeEffects
Other,patientsWithReducedBaselineLvef
Other,fitted
Other,variousArtifactsIntroducedDuringSlidePreparation
Other,malign
Other,tamoxifen-resistanceInErCancerCells
Variants,pathogenicVariantsInBrca1/2
Other,issues
Other,switched
Other,significantlyHigherPcrRatesThanPatientsWithLuminalTypes
Radiotherapy,evenSeveralChemotherapySessions
Other,dominantArms
Other,useful
Other,breastCancerSubtypesa
Hazard,lowRiskLesions
Other,earlyStageDiagnosisOfTumors
Other,urgent
Other,youngWomenWithInvasiveLobularCarcinoma
Correlation,correlationCoefficientOnMetabricTrainingSet
Other,G
Other,virtualRecombinedImagesFromLeImages
Other,Barshi
Other,threeCtcsIsolatedFromOnePatient
Other,breastCancerAged
Other,common
Other,characteristicsInsideTumors
Other,firmlyPlaceWithRecentTrendsTowardDecreasedRatesOfRe-excision
Other,oncogenes
Other,field
Other,patientsWithMeasurementErrors
Other,well-established
Other,willUsed
Other,mostCommonCancer
Other,referenceForClinicians
Other,revealed
Other,significantCausativeGenes
Other,effectivenessOfNationalScreeningProgrammes
Other,date
Other,inflammatoryDiseases
Other,Japan
Other,impededApoptosis
Other,patientsWithLocoregionalInSouthernPortuguese
Other,multivariateModelsAdjustedForIncome
Other,moreoverStronglyRecommended
Other,93Percecnt
Other,specialType
Advantage,good
Other,fieldOfMedicalImagesDiagnosis
Other,processing
Other,levels
Other,presented
Other,this
Other,diverseBiologicalProcesses
Other,organotropic
Other,R
Cell,canImportantToDiagnosis
Other,hasAlreadyAssociatedWithDifferentCancersNon-hodgkin'sLymphoma
Strategy,system
Other,unnecessaryFollow-upVisitsForWomenWithVeryLowRisks
Other,poor
Other,prognosesOfYoungMenWithBreastCancer
Other,metastaticDisease
Other,taiwanLongitudinalHealthInsuranceDatabase2005
Care,concernForExistenceOfCancerCellsInGrafts
Other,whenGiven
Other,withBetterDrugDeliveryPotentialOfNon-sphericalShapesHaveRecentlyInvestigated
Technique,excellentRegionalControl
Other,collected
Other,furthermoreMoreLikely
Other,only44Percecnt
Subtype,willDifferentRegardingSubtypeAtDiagnosis
Other,mayUsedForTumourShrinkagePriorToSurgery
Other,adjustingForPotentiallyConfoundingFactors
Other,pre
Subtype,differentSubtype
Other,thematicAnalysis
Hazard,RiskProtection
Advantage,relativelyGoodPrognosisWith5YearOverallSurvivalOf88Percecnt
Other,target
Other,57PercecntOfPatients
Other,73-yearOldWomanPresentingWithLeftBreastLumpClinicallyIndeterminate
Other,breastCancerCells
Cell,activityOfCellProliferationInBreastCancerCells
Other,theirPotentialClinicalImplicationsOnBreastCancer
Other,stillDifficult
Other,experimentalStudyOfCryo-stabilityOfCancerCells
Other,fused
Other,areaOfResidence
Other,moreEffectiveTreatmentOfLungCancers
Other,variables
Other,5Μl
Other,embeddingIntoReproducingKernelHilbertSpace
Other,intopreGroups
Other,important
Other,tissueStorageTime
Other,TAMs
Other,high
Other,opportunities
Other,mean
Other,48Years
Susceptibility,diminishedOncospheroid-formingCapacityOfBreastCancerCells
Other,neonatalOfRetrospectiveCohortOfPregnantWomenWith
Other,analysisOfLncrnaExpressionProfiles
Other,follow-up
Symptom,effectOfDdtSpraysOnBreastCancerIncidenceRate
Other,oestrogenReceptorCofactors
Other,alsoAssessedByQrt-pcr
Oxidation,greaterthanorequaltoReduction
Other,subtype-specificPrognosticSignatures
Other,detectionOfBreastCancerInWomen
Other,including
Other,retrospectiveStudies
Other,denseBreasts
Other,0.520
Other,mir-511Expression
Other,arms
Other,realNeedOfSurgicalTreatment
Other,hasApplied
Other,unusual
Other,inNearFutureContribute
Other,widelyUtilized
Exposure,model
Other,betterUnderstandingOfRisksAssociatedWithM
Other,lastFollow-upTime
Other,utility
Hazard,riskForRecurrence
Other,disadvantages
Other,hasMade
Other,developmentOfSubsequentLung/bronchusCancer
Other,importantlyCouldPotentialDiagnosticBiomarkerInEthnicPopulation
Other,alsoUsed
Other,robustTechnology
Other,RL
Other,correlationsBetweenOdds
Other,mir-193b-3pBinding
Other,protective
Other,haveBackbone
Other,relatedResearchDataOfDiagnosisOfInoperableLocallyAdvancedBreastCancer
Other,upregulated
Other,kaplanMeierCurves
Other,1984
Other,potentialTarget
Other,patientsWithHumanEpidermalGrowthFactorReceptor2
Other,PM
Other,protectiveFactors
Risk,secondLeadingCause
Other,needed
Other,immunocaptureOfMarker
Other,mostCommonCancerOfAdolescentsAgedAccountingFor56PercecntOfInvasiveBreastCancerInWomen
Cell,canDiagnosed
Other,massSpectrometry
Other,417Percecnt
Other,72Months
Other,BMI
Other,veryRareClinicalEntityWithOnlyFewCasesHavingReportedToDate
Other,discussed
Hazard,hazardRatiosWith95PercecntConfidenceIntervals
Symptom,heavySymptomBurden
Care,care
Other,thirdInTermsOfSpecificMortality
Other,moreInclined
Other,hasSuggested
Other,clinico-pathologicalFeaturesOfMetastases
Other,subsequentPrimaries
Care,standardOfCareAsFirst-lineTreatmentOfPatientsWithHer2-positiveAEvenInReal-worldSetting
Other,oneExtraVisit
Membrane,atrophiedVaginalMucosa
Resistance,shouldOvercomeBeforeClinicalApplication
Other,criticalScientificBaseForPrecisionMedicineInBreastCancer
Other,secretion
Other,shouldStaged
Subtype,specificSubtype
Neoadjuvant,neoadjuvantSetting
Other,tomography
Other,queried
Other,down-regulatedInTissues
Other,roleOfEstrogens
Other,independentPrognosticFactor
Other,193FemaleParticipants
Other,non-ideal
Other,mortalityRate
Other,histopathologicallyProvedBreastTumors
Other,totalGroup
Other,mostPrevalentMalignancyAmongWomenAroundWorldAreDiagnosedYear
Other,solidTumors
Other,pcrThanWomenWithHr-positiveTumors
Other,bilateralTotalMastectomies
Care,analyzedtheOperationTime
Paraneoplastic,mostLikelyParaneoplastic
Costs,costs
Other,roles
Other,62Years
Other,determined
Other,643PercecntWithSignificantDifferenceBetweenWhites
Other,baselineBpeLevels
Other,breastCancerConfinedWithinMammaryDuctsSurrounded
Exposure,theirQuestionableImpactOnMortalityOnIncidenceOfAdvancedTumors
Other,locoregionalDiseaseOfUnspecifiedLocation
Resistance,importantApplicationProspects
Other,effective
Other,pathogenic
Other,5-yearResultsOfPhase3Isg23-01Trial
Other,preoperativeAssessment
Other,patientsWithHer-2PositiveExpression
Other,inconsistentResults
Survival,survivalThanAdjuvantTherapy
Other,anticipated
Other,needsInPrevention
Other,retrieved
Other,surveillancePopulation-basedData
Other,positiveSln
Other,howeverWidelyUnderstood
Other,consistentMass-spectralData
Other,manifold
Other,scrutinised
Other,pregnancyOutcomes
Mechanism,theirContraceptivePreferences
Other,patientsWithNeoplasticDisease
Other,westernBlotAnalysis
Other,significantlyReduced
Other,er-dependentTranscriptionalActivationViaTransactivationFunction1
Other,cancerCounseling
Other,SpCM
Other,itsPoorPrognosis
Other,unknown
Other,advancedDiagnosticImaging
Exposure,reportOnPerformanceOfBayesClassifiersLikeTreeAugmentedNaiveBayes
Other,significantlyYounger
Other,anti-apoptoticEffectsOfEstradiol
Other,contextOfBreastCancer
Other,estrogen-aloneArmOfWhi
Image,heterogeneousDiseaseInItsHistologicAppearance
Other,Kazakhstan
Other,mostPowerfulTool
Other,associatedWithPfsAlthoughAtExtent
Other,balb/cNudeMiceBearing
Other,analyzed
Other,portugueseWomen
Other,thereforeCentralTarget
Other,mostCommonMalignantTumor
Other,related
Other,toEndDevelopedWithDrugToAntibodyRatioOf329
Other,42
Other,forRace/colorVariableEstimatedWithAdjustmentForStatus
Exposure,excellentPerformanceInFieldOfMedicalImagesDiagnosis
Other,manyResearchers
Other,stillObscure
Other,acid
Other,expressionOfMir-511InBreastCancer
Image,reverseActiveLearningForClassificationOfHealthyBreastTissue
Susceptibility,dryness
Susceptibility,mood
Other,humanErrors
Other,cross-sectionalCategories
Other,ronInternalization
Mechanism,association
Other,surgicalOptionsIncludingPreservationOfNippleAreolaComplex
Cell,canExtended
Cell,canDifficult
Other,moreAdvancedStages
Care,usualCare
Survival,survivalPrediction
Other,possibleCorrelationsWithClinicalStatusIncludingAge
Other,analyzedBeforeAnd
Survival,intralaboratoryValidationSet
Other,breastCancerPatients
Other,utilization
Other,included.When
Other,breastMetastasis
Hazard,asResultAreUsed
Other,dissectionOfLymphNodes
Survival,patientSelectionForNon-pcosReferenceCohort
Other,thenPresented
Other,leastAbsoluteShrinkage
Other,breastCancerPatientsWith1-2PositiveSlnspatientsWithBreastCancer
Other,localizedDescriptionOfBreastCancer
Other,assessments
Mechanism,associationBetweenRace/colorInWomenWithBreastCancer
Other,rapidBreast-cancer-tissueDiagnosis
Other,breastCancerTherapy
Other,determinationOfUnderlyingBiologyWithinTumors
Other,betterOs
Other,recurrence
Other,MSOT
Other,world
Other,achievedForHer2Status
Other,status
Other,women'sCancerAccounting
Other,49CedmCasesCollectedFromMayoClinic
Other,followedFromDateOfFirstDiagnosisOfAdToEndOf2013
Other,differentialDiagnosisInPatientsWithHistoryOfBreastSurgery
Other,diet
Advantage,goodDiagnosticPerformance
Other,diagnosisOfBreastCancer
Other,report
Other,howeverUnderutilized
Other,megakaryocyteMarker
Other,formed
Other,future
Other,prognostic
Other,henceMajorResearchGoal
Resistance,resistance
Other,0.0001
Other,univariableLogisticRegressionModels
Other,subsequentMalignancies
Image,active
Other,12EventsAmong121Patients
Other,theirOwnParticularity
Other,methods
Other,subsequentCancerCounselingOfFemaleSurvivors
Other,used
Other,prevalenceOfobesityOf277Percecnt
Other,visualizedTheranosticsOfTumors
Other,therapeuticTargetForPotentialTreatment
Cell,canUsed
Other,third-lineTreatmentForAdvancedTriple-negativeBreastCancerthisRetrospectiveStudy
Other,grafts
Other,lower
Other,potentialBiomarkerForCancerDiagnosisThanMrnaBiomarkers
Other,hasProposed
Other,breastTumorMicroenvironment
Other,tumorGrowth
Other,reference
Other,17MillionPeople
Other,neglected
Other,moreRefinedStratificationThanAnatomicStageAlone
Other,nationwideRegistries
Other,unclear
Symptom,evidence
Other,strong
Other,importantContributors
Other,poorAdhesion
Other,twoCasesOfMimicsOfBoneMetastasis
Mechanism,roleOfPdgf-b/pdgfr-betaAxisInRareTypesOfBreastCancers
Other,cnvData
Other,value
Susceptibility,associationsOfPhysicalActivityInGlobalHealthInBreastCancerSurvivors
Other,tumor-1
Other,tumorigenesisOfCells
Glycosylation,glycosylationOfMembraneTypeMr
Other,effects
Other,seen
Other,secondaryConfirmationOfSignalAccumulationUsingNearInfraredFluorescentImaging
Other,ctcsFromPeripheralBlood
Image,correspondingHistologyImage
Other,highlyExpressed
Other,moreEasilyHypomethylated
Other,bilateralBreastLumps
Other,breastCancerTissueMicroarrayWithAccessToReceptorAnalyses
Other,2IndependentCohorts
Other,32620MatchedPatientsWithoutPcos
Other,excision
Other,11BreastRadiologists
Other,popular
Other,cells
Other,healthInitiative
Other,broadDifferentialDiagnosis
Other,aimed
Cell,canCategorizedIntoSubtypesOfLuminalA
Other,molecularPathwaysInvolvedInPathogenesisOfProliferation
Other,radioisotope
Other,higherRisks
Other,notablyDesigned
Other,variousImportantFunctions
Other,thatOfMir-511
Susceptibility,improvement
Other,byWhichObservedInNondestructiveWayThroughThermalAnalysis
Other,abstractDataOnTheirClinicalCharacteristics
Other,associated
Other,medicalHistory
Other,optimalTherapeuticTargetForPatientWithAdvancedBreastCancer
Other,mostRelevantKind
Other,481Women
Other,followed
Other,type160Patients
Other,Development
Other,hasFocusedOnTumourCellsPrimarily
Hazard,increasedRiskWithUseOfLevonorgestrelIntrauterineSystem-bothOfPotentiallyImportantFindings
Other,comparedBetweenMetastaticSlns
Other,commonMalignancyWorldwide
Phenotype,alongsideRoutineMethodEmployedOnTexture
Autoantibodies,roleOfAutoantibodiesInEarlyCancerDiagnosis
Other,higherProportion
Cell,variousCellularProcessesCellCycleRegulation
Other,inexpensive
Exposure,greatClinicalImpactForTumorDiagnosis
Other,typical
Other,EMH
Other,13
Other,haveAssociated
Other,younger
Other,pH
Other,mostPrevalentMalignancyDiagnosedInPregnancy
Advantage,importantCopingResource
Other,99PercecntAccuracyInTermsOfClassification
Care,cancerCareSystems
Other,planning
Other,suutaneousLymphaticChannelsInReal-time
Other,S+RT
Other,efficientSignaturesForClinicalDiagnosis
Susceptibility,publicHealthChallenge
Other,malignantProgressionOfBreastCancer
Exposure,randomEffectsModel
Cell,inStudyFusedWithMouseMyelomaCellLineSp2/0InPresence
Other,complex
Other,heterogeneousPopulationsOfCellsWithHierarchicalOrganizationDrivenByCancerStemCells
Other,CMIA
Other,adherenceToEhtAmongBreastCancerPatients
Other,broadcasted
Other,crucial
Other,couldIndependentPrognosticBiomarkerForMPatients'Outcomes
Other,earlyStage
Other,understanding
Other,problem
Other,976PercecntSensitivity
Other,anti-oncogenicRegulationOfMir-34s
Mechanism,potentialMechanism
Other,clinicalFeasibilityOfCtcIsolation
Other,kernelApproach
Other,training
Signature,interval
Signalling,eralphaSignalling
Other,enrolled
Hazard,peakInRecurrenceRisk
Other,study
Image,itsHistologicAppearance
Other,quality-of-lifeFactorsForSurvivorsIncludingSexualDysfunction
Other,medicalDiagnosisOfBreastCancer
Symptom,firstSymptom
Other,handheldProbeCapable
Other,group
Other,delivery
Other,developmentOfBreastCancer
Other,clinicalVisits
Other,developmentOfEffectiveDrugsForTreatmentOfHormone-dependentBreastCancer
Other,moreoverRemarkablyIncreased
Cell,theyCanImpactOnQualityOfLifePresent
Exposure,potentialImpactOnFertilityAfterTreatment
Other,sensitive
Other,rrm2Expression
Other,thatInMabaGroup
Care,conflictBetweenCareOfMother
Other,oedema
Mechanism,associationBetweenPreviousCervicalCancerScreeningInBreastCancerScreening
Other,base
Other,overnight
Other,twoCases
Other,2-3Years
Other,KDM4B
Other,detectedThroughScreeningThroughSigns
Other,50
Image,memorialSloanKettering-integratedMutationProfilingOfActionableCancerTargets
Exposure,familyImpact
Other,positivelyAssociated
Other,minimalRisksToNormalCells
Other,small
Other,sixteenRegionsOfKazakhstan
Technique,breastCancerControlEfforts
Other,differentPhenotypes
Other,benign
Other,previousStudies
Other,issuesRelatedToTherapeuticSequencingInLocalTherapyOfBreastCancer
Other,GTPase
Hazard,riskFactorsOfLviByMultivariateAnalysis
Other,closelyAssociated
Other,life
Care,interventionArm
Other,population-basedStudies
Other,variableMolecularMechanismsOfCarcinogenesis
Other,pureDcis
Other,biomarkers
Other,specificCancerCell-relatedComponents
Other,blackWomen
Other,hypothesis
Survival,threeOverallSurvival
Other,recentlyHaveUsedAsBiomarkers
Other,binding
Survival,surgicalExcisionWithRadiation
Other,required
Other,analysed
Other,only20Percecnt
Other,pairedTumor
Susceptibility,harmToHealthAmongRuralWomenWithIncrementalCost-effectivenessRatio
Susceptibility,capacity
Other,included
Phosphorylation,phosphorylation
Other,englishLiterature
Other,perturbation
Other,expressionOf6CirculatingMirnasInOperablePatients
Other,whereDeveloped
Other,differentContrastAgent
Other,conducted
Other,9EuropeanCountries
Other,standardMethodForEvaluationOfProposedPrognosticTumourMarkers
Other,investigated
Other,significantlyAssociated
Other,erCscs
Other,whereFacilitatedBySurfaceModificationOfNps
Other,analysis
Other,proliferation
Other,osteopontinPeptide
Quantification,feasibleInProperlySelectedCasesWithAsymptomaticNeuromasAfterAccurateTissueSampling
Other,chapter
Other,CTCs
Other,tissueMicroarray
Other,incidentalFinding
Other,understandingOfEmergingConceptsOfTumorBiology
Other,determine
Signature,partialPathologicalResponseWithLargeAreasOfTumourRegression
Other,information
Other,earlyDiagnosis
Other,testingDatasetsCollectedFrom48Patients
Other,CTC
Other,missed
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneInCombinationMainlyWithTrastuzumab
Other,youngMexicanWomen
Other,mammaryMetastasisFromCarcinomaOfOvarianOrigin
Other,histopathologicalExamination
Other,clarify
Hazard,shouldPerformedInAtRisk
Other,PI3K/AKT/mTOR
Other,independentPrognosticPredictor
Other,preclinicalModels
Other,mostFrequentMalignancy
Other,lungCancerInHuman
Other,prognosticMeritOfNek6ExpressionInBreastCancer
Image,whenActiveUse
Mechanism,barrierFunction
Advantage,willLeadToMortalityReductionsWithoutUsualScreeningHarms
Other,significantlyUp-regulated
Other,postmenopausalWomenWithDevelopmentOfBreastCancer
Other,Anemia
Other,recentYears
Other,protectiveFactor
Other,q12X
Other,breastTumorProgression
Other,illiterate
Exposure,zebrafishTumorModel
Other,secretionOfTumorNecrosisFactor
Other,majorCscMarkersDescribedInInvasiveBreastCancer
Other,insufficient
STs,stsOfDeath/relapse
Other,dependentOnRigorousPathologicEvaluationOnAdministrationOfTreatmentDictatedByTumorBiology
Other,643Percecnt
Other,fabricated
Other,boneDensity
Other,knowledge
Hazard,riskFactorsOfLvi
Other,disease
Other,845Percecnt
Other,performedFromInceptionToJanuary312018
Other,mainlyEurope
Sites,sites
Other,applied
Technique,advantageOfHigh-throughputLuminexTechnique
Other,bulkyHighlyTechnical
Other,only35Cases
Other,infiltrativeLesion
Other,alreadyWell-established
Other,lymphedemaPatients
Other,identified
Vivo,evaluatedInVivo
Other,chronic
Other,lowDiagnosticSensitivityForWomenWithDenseBreasts
Other,fewPercentOfWomen
Other,westernizedCountries
Care,clinicalCharacteristicsOfCareOfBreastCancerPatients
Other,threeYearsBeforeAge64Years
Other,featuresFromImages
Other,broadUseToPatients
Susceptibility,healthBehaviours
Other,patientsWithHer2
Cell,moreoverPerformedOnMcf-7CellLineInPresenceOfCs/bio-mofCarrier
Other,mistakenDiagnosisOfMalignancy
Other,decades
Other,twoYears
Other,distributions
Other,diagnosticAccuracy
Other,markedlyUp-regulated
Other,period
Other,resistant
Other,willTested
Other,show
Other,patientsWithBreastCancer
Other,13Percecnt
Other,inverselyCorrelated
Other,tumor-bearingMiceOfMcf-7BreastCancerCells
Other,phForHer2AgainstHer2-overexpressedBreastCancer
Other,standardBiomarkerTestingByImmunohistochemistry
Other,MCC
Image,caseOf68-year-oldCaucasianFemaleWithFamilyHistoryOfCancer
Other,particular
Other,vap-1Staining
Hazard,riskStratification
Other,comparedToThoseWithPregestationalBreastCancer
Exposure,impact
Other,contrast
Other,detectionRateOfMutationsHigherThanThatDescribedInLiterature
Other,onEsophagogastroduodenoscopyIdentifiedInAntrum
Other,patientEducationIdentification/reportingOfSideEffects
Other,suchLowIncidence
Other,inTotalMatchedToCasesOnBirthYear
Other,cancerMolecularDiagnosis
Other,whenSuspected
Other,adverseEventsExceptDegreeI-iiBleeding
Other,subsequentlyAssessed
Other,oneScreeningProgramme
Other,includedInStudy
Other,ourStudy
Other,management
Other,empiricalTreatmentsBasedOnClinical-pathologicalCharacteristicsToUseOfTargetedApproaches
Other,strongContrastWithImagingModalities
Other,treated
Other,distinct
Other,drawbacks
Other,potentialTherapeuticTarget
Hazard,earlyBiomarkersOfBreastCancerRisk
Other,femalePatientsWithAd
Other,urgentClinicalProblem
Hazard,result
Other,0.02
Survival,10-yearBreastCancerSurvival
Other,detectionOfMicrocalcificationInMammograms
Other,intravenousAdministrationOfOsteopontin-750Probe
Other,lessVisits
Other,highMortalityRateForFemales
Other,brca-associatedCancers
Other,Fbxo22
Other,hasPutOnIntrinsicSubtypingBasedInPresenceOfClassicalImmunohistochemistry
Other,clinicalBreastExaminationCoupledAsPrimaryTool
Other,couldDetected
Other,dnaMethylationDifferencesBetweenTumorBreastTissue
Other,mostPervasiveTypeOfCancerAmongWomen
Other,thereforeCriticalSignificance
Other,pcdh10GenePromoterMethylationIdentifiedInDuctalCarcinoma
Other,prognosticSignificanceOfNlrInEarlyStage
Other,S
Other,poorerPrognosisInWomenWithBreastCancer
Other,876Percecnt
Other,bt549Cells
Care,attention
Other,WES
Other,differentStages
Care,perceptionOfQualityOfCareProvidedByCancerCareNetworkForEarlyDetectionOfBreastCancer
Other,greatPotentialInDiagnosisTherapyOfCancers
Other,mir-193b-3pIdentifiedAsRegulator
Susceptibility,theirHealthBehaviours
Other,present
Heterogeneity,heterogeneity
Other,preciseToolForTargetedTreatmentOfCancerIncluding
Mechanism,associationOfPcdh10Methylation
Other,haveDescribed
Radiotherapy,neoadjuvantChemotherapy
Other,
Symptom,effectOfBaicalinInBreastCancer
Other,howeverHaveClarified
Other,function
Phosphorylation,phosphorylationOfAkt
Township,country
Other,bestStandardTreatmentRegimenAvailable
Other,prognosis
Radiotherapy,systemicChemotherapy
Other,contrastAfterInjection
Other,saudiArabianWomen
Other,x-rayMammography
Risk,leadingCauseOfDeathAmongGynecologicNeoplasias
Other,betterAccessToAtertiaryCancerCenter
Cell,canTherapeuticTargetForNextGenerationOfSerms
Regulatory,positiveRegulatoryFeedbackLoopForFxyd3Amplification
Other,thusPotentialTherapeuticTarget
Other,medianFollow-upOf48Years
Hereditary,mustAddressedDuringCancerGeneticCounselingConsultations
Other,aspects
Susceptibility,globalHealth
Other,access
Other,expressionOfRrm2
Other,replaced
Other,breastCancerMcf-7
Other,dependent
Other,pcosGroups
Other,moreTargetedAdjuvantTreatments
Other,foundBetweenMolecularSubtypesWithHer2
Other,insights
Other,inConclusionStillNecessaryForAdoptionOfCtnAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
Other,investigatedOnly
Other,resources
Parameters,intravoxelIncoherentMotionParameters
Other,cancerCells
Other,Chi
Other,moreIntensiveFollow-up
Other,DPV
Resistance,choiceOfChemotherapyInBrca-associatedCancers
Other,procedure
Other,120BreastCancerPatients
Mechanism,bodyWeight
Other,mayDistinctEntity
Toxicity,minimumToxicityToNormalCells
Other,hormoneReceptor-positiveTumors
Other,automatedAnalysisOfClinicallyRelevantHistopathologicFeature
Other,lowCountries
Other,stageIi
Other,method
Symptom,novelStrategiesForDiagnosisOfBreastCancerWithHyperglycemia
Other,greater
Other,accomplished
Other,deathInWomenWorldwide
Other,highlyPenetrantGenes
Other,relationshipBetweenStromalExpressionOfPodoplaninInInvasiveBreastCarcinoma
Other,bevacizumab-relatedCardiotoxicity
Other,differentiation
Other,breastCancerGrading
Hazard,outcomeInEr-positive/humanEpidermalGrowthFactorReceptorType2-negativeBreastCancersWithHighHazardRatiosIndependentlyOfOtherMarkers
Other,youngWomen
Other,opticalCoherenceTomographyImages
Other,breastCancerModels
Other,developed
Other,nature
Other,3GroupsBasedOnTertiarySolubleSt-2Level
Other,soFarHasMainlyAssociatedWithMutationsInBrca1
Technique,noninvasiveImagingTechniqueForBreastCancerDiagnosis
Other,richSpectralFeaturesOfPhenyboronicAcid-basedNanoprobe
Other,group2
Other,complexDueToPotentialFoetalRisksInSettingOfMaternalTreatment
Other,young
Cell,canOnlyDiagnosedOnPresentationOfSymptoms
Other,significantlyCorrelated
Other,estrogen-receptorAmongOtherMarkers
Other,different
Other,clinicians
Other,indicative
Other,inclined
Mechanism,associationBetweenTumorUptakeInInvasiveDuctalCarcinoma
Other,metastasectomy
Other,matched
Other,decreasesInMortalityRates
Susceptibility,noticeableDrugLoadingCapacity
Other,receiverOperatingCharacteristic
Other,assessment
Other,pregnancy
Other,tumorNecrosisFactor
Other,roleOfSupportOfferedByVirtualCommunitiesToBreastCancerPatients
Symptom,cell-killingEffectInTriple-negativeSubtypeMda-mb-231Cells
Other,mortalityRates
Other,505PercecntOfAnalyzedCases
Other,0.029
Symptom,symptom
Other,dcisWithMicroinvasion
Technique,60ControlPatients
Other,medications
Image,february2012InNargisDuttMemorialCancerHospital
Other,breastCancerMolecularSubtypes
Hereditary,differentGeneticProfile
Other,inBelgiumMostFrequentWomen'sCancerAccountingForTo353PercecntOfCases
Other,childbearingReasonsIncluding
Other,known
Other,tendency
Other,oftenDebated
Other,features
Other,that
Cell,cellCycleRegulators
Other,obtainedFromPatientsWithBreastCancer
Other,age
Other,screened
Exposure,itsDiagnosticPerformance
Other,252Percecnt
Sites,otherSites
Other,earlyBreastCancer
Cell,canStartedAtVeryEarlyStage
Other,at25HPost-injectionGreaterInTumorBedThanInKidneyRespectively
STs,STs
Other,miR-204-5p
Cell,canConsidered
Other,cancerDeathAmongWomenWorldwide
Other,timeInMostCountries
Radiotherapy,practicalImplicationsOfOngoingChemotherapy
Other,womenWorldwide
Other,currentCancerResearch
Sites,sixGlycosylationSites
Other,promoterMethylationInCertainTypesOfHumanTumors
Symptom,qualityEvidence
Other,firstTime
Other,willTestedThroughEuropeanMyPersonalBreastScreening
Other,0.001
Other,womenWithBreastCancer
Other,1H
Other,postmenopausalwomen
Other,f-boxProtein22
Other,stat1RecruitmentToEralphaPromoterRegion
Other,sensitivityOf786PercecntRespectively
Other,painless
Other,faSignalingNetwork
Other,tripleAssessmentFollowed
Other,30DoublingTimesNecessary
Other,hasWidelyUsed
Other,detectedByImmunohistochemistryInApproximately70PercecntOfInvasiveBreastCancers
Other,significanceOfTime-trends
Other,follow-upSchemes
Other,roleOfPrimaryCaregiver
Other,proliferationOfMcf-7Cells
Signature,diagnosisOfResponseToTreatment
Other,thusCritical
Other,positivelyCorrelated
Other,diagnosed
Hazard,cardiotoxicRisk
Other,regulationOfNras
Susceptibility,identificationOfPredictiveBiomarkersForSelectionOfOptimalTreatment
Other,baGroup
Other,vital
Other,1722Comments
Survival,survival
Other,case
Other,womenWithMore70PercecntOfPatientsTreatedWithHormonalTherapy
Other,similarSeriousAdverseEvents
Exposure,questionnaireBasedOnAnderson'SdelayModel
Other,chosen
Other,completionOfReproductivePlans
Other,expressed
Other,pathologyForFurtherFollow-up
Other,preservationOfBiomarkerExpressionInOldFfpeTumour
Other,normalDucts
Other,fluorescenceImaging
Hereditary,case-controlAssociationStudyForVariantsInCodingRegionsOf11HereditaryBreastCancerGenesIn7051UnselectedBreastCancerPatientsOfJapaneseAncestry
Other,evaluation
Other,thereforeAdministered
Other,thanDcis
Other,assay
Cell,panelOfCellLinesWithDifferentPhenotypes
Survival,itsMinimalSilverIonReleaseProfiles
Other,regression
Other,estrogenReceptor
Other,debated
Symptom,oftenWellScrutinisedByPathologistsForEvidenceOfMetastaticCarcinomaAsImportantPrognosticParameterInStandardSetting
Other,secondDecadeAfterDiagnosis
Other,ourPreviousWorkRegardingToPropertiesOfPluronicsWithDifferentPhotosensitizerForPhotodynamicTherapy
Other,ranging
Other,descriptive-analyticCross-sectionalType160FemalePatientsWasselected
Other,decreased
Other,evenLessFrequentComplication
Other,4Categories
Other,users
Other,initialTreatmentAfterWhich
Other,higherProportionOfPatientsWithLymphedema
Other,sexualStigmatizationOfM
Other,doublingTimeOfOccult
Other,resultsOfStudy
Survival,radiation
Other,differentFunctionRegions
Other,needForAwarenessOfMimicsOfBoneMetastasis
Hazard,theirRisk
Other,pleuralDiseaseProgression
Biopsy,biopsy
Resistance,tamoxifenResistance
Other,protected
Other,differenceBetweenDifferentBreastCancerSubtypes
Other,cscMarkers
Other,microscopicImages
Other,assessed
Other,breastCancerGenes
Other,probablyTranscriptionalActivation
Other,dscam-as1Expression
Other,overallLowOfSixCirculatingMirnas
Hazard,outcome
Other,foundInPcosCohortThanInComparisonCohort
Other,haveUsed
Other,consequencesForSurvival/relapse
Other,relativeThose
Other,proteinS-100
Care,widelyAcceptedAsStandardOfCareFollowingBreastConservation
Other,significantlyHigherBaselineBpeLevelsThanPostmenopausalWomen
Other,standard
Other,nextMade
Hazard,adjustedHazardRatio
Hereditary,inConclusionMajorHereditaryBreastCancerGenesIrrespectiveOfAgeAtDiagnosisInJapaneseWomen
Other,proportion
Other,125DogSeraSamplesIncluding75MammaryTumourSera
Other,based
Other,ronReceptorTyrosineKinase
Resistance,course
Other,couldDetectedEarly
Other,moreLikely
Hazard,riskFactor
Care,neededAcrossCareContinuumEspeciallyInLow-resourceSettings
Other,similar
Signature,inMarch2014BroadcastedAsPart
Other,loss
Susceptibility,generalHealth
Other,pleurodesis
Other,patientsByTrastuzumab-pretreatment
Other,4
Other,SVM
Exposure,potentialImpact
Other,areUsed
Other,alive
Other,5Of10Patients
Other,fourTypesOfBreastCancer
Other,thatInNon-pcrGroup
Other,averageOf425±496Ctcs/2Ml
Other,large
Other,historyOfBreast-conservingSurgery
Other,timeIntervalsFromFirstDetectionToDiagnosis
Other,expressionProfileOfNek6In133BreastCancerSpecimens
Other,advancedBreastCancerBearingMutationsInGenesInvolvedInPi3k/ark/mtorSignalingPathway
Other,news
Other,secondSurgery
Susceptibility,thereforeHasAppliedToEarlyIdentification
Other,participantsWithBreastCancer
Other,expressedSeparately
Hazard,riskOfDevelopmentOfGliomas
Susceptibility,moreResearchLight
Other,humanBiofluid
Hereditary,inheritableBi-objectiveCombinatorialGeneticAlgorithm
Other,accessToEarlyDiagnosis
Other,trend
Other,mrnaExpressionLevelOfPcdh10
Other,sideEffects
Membrane,panel
Other,expression
Other,treatingMedicalTeam
Other,90PercecntOfPatientsWithRecurrence
Other,possibility
Other,localTherapyOfBreastCancer
Other,malignant
Correlation,correlation
Other,confirmedUnilateralHer2-positiveBreastCancer
Other,patientsOnAromataseInhibitors
Other,D538G
Other,personalGoal-setting
Hazard,individualRiskOfRecurrence
Other,51Days
Other,robust
Other,agents
Other,statisticallySignificantValuesAt4Cells/7MlBlood
Quantification,periodOfObservation
Other,mostCommonAgentsUsedInBreastCancerTreatment
Cell,inPresentStudyConductedBetweenMcf-7Tamoxifen-resistantLcc2CellLines
Symptom,clearEvidenceForbenefitsOfTanUsageInBreastCancerClassification
Other,China
Other,findings
Other,harmfulorHarmlessTissues
Other,treatment
Other,urgentlyDeveloped
Other,descriptiveStudy
Other,worldwide
Other,painlessLumpInBreastAccountingFor688PercecntOfPatients
Other,trastuzumabInitiation
Other,satisfied
Other,substantialDiscordancesBetweenPrimaryTumors
Other,clinicalVariablesAmongDifferentGroups
Other,2012AtBreastClinicOfPortugueseInstituteOfOncologyInPorto
Other,thenClassifiedBySupportVectorMachines
Other,992PercecntOfCases
Other,context
Other,vitalRoles
Other,howeverSwitched
Other,therebyFrequentlyNeglected
Other,driven
Radiotherapy,neoadjuvantChemotherapyWithHerceptin
Other,.014
Other,recognizedAsCtcIn1Of15HealthyBloodSamples
Other,found
Other,hasReported
Other,AUC
Other,1YearTo5Years
Other,treat
Other,complementaryApproaches
Other,expressionInBreastCancer
Other,surveillanceData
Other,axillaryClearance
Resistance,potentialApplicationForDiagnosisOfCancerInFuture
Other,localExcision/lumpectomy
Other,earlyBreastCancerSurgery
Other,68Percecnt
Other,highDetectionRateOfSentinelLymphNodeComparableWithRiMethod
Other,referral
Other,documented
Other,developmentOfLymphedema
Other,knowledgeOfM
Other,hasRecentlyProposedAsCrucialRegulatorOfTriple-negativeBreastCancer
Other,newDesignDouble-layerCapacitors
Other,understand
Cell,cellInvasion
Other,sleepDisturbances
Sites,averageOfFiveInvolvedSites
Hazard,decreasedRiskOfBreastCancerInFemaleAdPatients
Other,invasiveCarcinomaBreast
Other,obscure
Other,accurateDiagnosisOfBreastCancerSubtypes
Other,neutralEffects
Other,safety
Other,proliferationOfCells
Other,radiomicsScore
Exposure,crucialImpactOnDevelopmentOfBreastCancer
Other,neuralNetworkClassifier
Other,uncover
Other,inHumanBreastCancerHasReported
Other,inPrimaryBreastCancerTumorsExpressedDuringNeoplasticTransformation
Other,fastDayBefore
Other,qualitativeApproach
Other,formedByCo-encapsulationOfNear-infraredFluorophoreInPegylatedMicelles
Other,connected
Other,mustIndividualized
Other,amount
Other,patientsWithHistoryOfBreastSurgery
Other,kind
Other,receivedWithoutSurfaceModification
Other,shouldPerformed
Long-term,inLongTermHasFound
Other,2=
Other,involved
Other,childHealth
Other,events
Other,pcrResults
Other,misdiagnosis
Other,Herceptin
Other,hasInconsistent
Other,specificCircumstances
Other,cases
Other,veryComplexDisease
Other,patientsWithMetastaticBreastCancer
Other,analyzedRetrospectively
Other,logisticregressions
Other,us
Other,newOpportunitiesForDevelopmentOfNovelTherapeuticStrategies
Other,europeanCountries
Other,canines
Exposure,performance
Other,7051UnselectedBreastCancerPatientsOfJapaneseAncestry
Other,multipleBiological
Other,multicenterStudy
Other,er-positiveBreastCancer
Other,thereforeRequired
Other,estimated
Other,patientsWithMAmongThem
Other,qualityOfLife
Other,alarmingLevelGlobally
Other,preclinicalPhase
Other,issuesOfExistingContrastAgents
Hazard,riskFactorForLung/bronchusCancer
Other,preventionOfDiagnosedBreastCancerInEstrogen-aloneArmOfWhi
Other,slnMetastasis
Correlation,matthewsCorrelationCoefficientOf8038Percecnt
Other,independentlyAssociated
Quantification,whole-tumorSamplingOfDiseaseBurden
Cell,breastCancerCellInvasion
Other,timeOfTheirAppointmentwithDoctor
Other,characterized
Other,importance
Other,inConclusionDownregulatedInBreastCancer
Other,changes
Other,risksOfLate-stageDiagnosis
Other,markerBands
Other,massInPosteriorFossaOfBrain
Other,microscopicTestingOfHematoxylin
Other,thoseWithHr-positiveTumors
Other,postoperativeComplications
Other,howeverMuchLower
Other,blood
Other,veryHeterogeneousDisease
Other,radiologicalSignsOfMalignancy
Other,67BreastCancerSamplesFrom66Patients
Other,detectionOfCancer
Other,modified
Other,tumorEasily
Resistance,activity
Other,average
Image,multiyearCollaborationLedByUnionForInternationalCancerControl
Other,comparedBetweenPremenopausalGroupsBetweenPcrGroups
Hereditary,hereditaryCausesOfChorea